Caspase-8 (encoded by the CASP8 gene) is the initiator caspase of the extrinsic apoptosis pathway, activated at death receptor complexes. As a member of the cysteine-aspartic protease family, caspase-8 plays a central role in transducing extracellular death signals into intracellular proteolytic events that execute programmed cell death . Its activation at the death-inducing signaling complex (DISC) triggers both the extrinsic apoptotic pathway (direct activation of executioner caspases) and the intrinsic mitochondrial pathway (via Bid cleavage). Beyond apoptosis, caspase-8 regulates necroptosis (by cleaving RIPK1 to prevent kinase-driven necrosis), influences cell proliferation and differentiation, and modulates immune cell activation and inflammation. Dysregulated caspase-8 activity contributes to cancer (insufficient activity allows tumor cell survival) and to neurodegenerative diseases (excessive activation causes neuronal death) .
| Caspase-8 Protein |
|---|
| Protein Name | Caspase-8 (FLICE, MACH) |
| Gene | [CASP8](/genes/casp8) |
| UniProt ID | [Q14790](https://www.uniprot.org/uniprot/Q14790) |
| Molecular Weight | ~55 kDa (procaspase-8), ~43 kDa (active p18/p10) |
| Subcellular Localization | Cytoplasm, plasma membrane (DISC) |
| Protein Family | Caspase family (cysteine protease) |
Caspase-8 is synthesized as a zymogen (procaspase-8) of 479 amino acids with a characteristic domain architecture:
¶ Protein Domains
- Death effector domain (DED1) (residues 1-100): N-terminal DED — mediates homotypic interactions with the adaptor protein FADD via DED-DED binding. Critical for DISC recruitment.
- Death effector domain (DED2) (residues 100-200): Second DED — structural role, stabilizes the DED region. Mutations in DED2 can cause autoimmune lymphoproliferative syndrome (ALPS).
- Linker region (residues 200-260): Flexible region containing the intersubunit cleavage site (Asp210, Asp216). Serves as the autocatalytic cleavage substrate.
- Large subunit (p20) (residues 260-374): Contains the catalytic dyad (His277, Cys360) — histidine acts as the general base, cysteine is the nucleophile. Major determinant of substrate specificity.
- Small subunit (p10) (residues 374-479): Completes the active site, contributes to substrate recognition. Contains the C-terminal cleavage site (Asp374) that separates p18 from p10.
Procaspase-8 activation involves:
- Dimerization: Two procaspase-8 molecules are brought into proximity at the DISC. Dimerization is the primary activation event — it occurs via the protease domain interface, not through the DEDs.
- Intersubunit cleavage (Asp210, Asp216): Dimerization-induced conformational changes allow trans-processing at the linker sites, separating p18 from p10 within each molecule (but not yet separating the two subunits).
- Autocatalytic processing (Asp374): Final cleavage at Asp374 separates the large and small subunits, generating the active p18/p10 heterotetramer. This is irreversible.
- Active form: The active caspase-8 is a (p10)2-(p18)2 heterotetramer with two catalytic sites, released from the DISC into the cytoplasm.
Caspase-8 also exists in a stable (p43)1 form, generated by cleavage at Asp210, which remains associated with the DISC and may have non-apoptotic signaling functions.
Caspase-8 is the central mediator of death receptor-initiated apoptosis :
- Receptor activation: A death ligand (FasL, TNF-α, TRAIL) binds to its cognate receptor (Fas/CD95, TNFR1, DR4/DR5), inducing receptor trimerization or oligomerization
- Adaptor recruitment: The intracellular death domain (DD) of the activated receptor recruits FADD (Fas-associated via death domain) via DD-DD interactions
- DISC formation: FADD recruits procaspase-8 via DED-DED interactions, forming the death-inducing signaling complex (DISC). This is the signaling hub for extrinsic apoptosis
- Caspase-8 activation: Within the DISC, high local concentration of procaspase-8 drives dimerization and autoproteolytic activation
- Substrate cleavage: Active caspase-8 is released from the DISC to cleave downstream substrates
Caspase-8 has a preference for the tetrapeptide sequence (I/V/L)X(E/D)X(D/I) and cleaves many substrates:
- Executioner caspases (caspase-3, -6, -7): Direct cleavage activates these effector caspases, which execute the apoptotic program
- Bid: Cleavage of the BH3-only protein Bid generates tBid (truncated Bid), which translocates to mitochondria and induces cytochrome c release — this links extrinsic signaling to the intrinsic mitochondrial pathway
- PARP: Cleavage of poly(ADP-ribose) polymerase inactivates DNA repair, committing the cell to death
- Structural proteins: Lamin A/C, actin, beta-catenin — dismantling of cellular architecture
- RIPK1: Cleavage separates the kinase domain from the death domain, preventing necroptosis
Caspase-8 is a critical suppressor of necroptosis :
- RIPK1 cleavage: Caspase-8 cleaves RIPK1 at Asp324, preventing the assembly of the necrosome (RIPK1-RIPK3-MLKL complex)
- Switch function: Caspase-8 acts as a molecular switch between apoptosis (sufficient activity) and necroptosis (caspase-8 inhibited or absent)
- Necroptosis in neurodegeneration: In some contexts, caspase-8 inhibition leads to necroptotic neuronal death, which is particularly inflammatory and damaging
- Cell proliferation: Caspase-8 activates NF-κB via the IKK complex, promoting cell survival and proliferation
- T cell activation: Required for activation-induced cell death (AICD) in T lymphocytes
- Embryonic development: Casp8 knockout mice die in utero with cardiac defects and impaired vascular development
- Immune regulation: Modulates macrophage polarization and cytokine production
Caspase-8 activation contributes to neuronal apoptosis in AD:
- Aβ-induced activation: Amyloid-beta oligomers activate caspase-8 in cultured neurons and in AD brain tissue
- Death receptor involvement: Fas/FasL signaling is upregulated in AD brain, contributing to caspase-8 activation
- Synaptic damage: Caspase-8 cleavage of synaptic proteins (Arc, PSD95) may contribute to early synaptic dysfunction
- Cross-talk with tau: Caspase-8 can activate executioner caspases that promote tau cleavage and aggregation
- Therapeutic targeting: Caspase-8 inhibitors (z-IETD-fmk, specific peptides) reduce neuronal death in AD models
In PD, caspase-8 is activated in dopaminergic neurons undergoing degeneration:
- Death receptor activation: Fas, TNF-R1, and DR4/DR5 are expressed on dopaminergic neurons and can activate caspase-8
- Mitochondrial links: The Bid cleavage pathway connects extrinsic signaling to mitochondrial dysfunction, a hallmark of PD
- Endoplasmic reticulum stress: ER stress triggers caspase-8 activation in dopaminergic neurons via mechanisms that remain partially characterized
- Neuroinflammation: Microglial-derived TNF-α and FasL can activate caspase-8 in adjacent neurons
¶ Glaucoma and Optic Neuropathy
Caspase-8 is activated in retinal ganglion cells (RGCs) during glaucomatous neurodegeneration :
- Axonal insult: Elevated intraocular pressure causes axonal transport disruption, leading to caspase-8 activation in RGCs
- ProBDNF signaling: The p75NTR proBDNF pathway activates caspase-8 in retinal neurons
- Therapeutic potential: Caspase-8 inhibition is neuroprotective in mouse models of glaucoma
¶ Stroke and Ischemia
Ischemic brain injury prominently activates caspase-8:
- Excitotoxicity: Glutamate-induced overactivation of NMDA receptors triggers caspase-8 activation
- Fas/FasL upregulation: Ischemia induces Fas expression on neurons and FasL on endothelial cells and microglia
- Dual pathways: Both direct caspase-8 activation (extrinsic) and Bid-mediated mitochondrial amplification (intrinsic) contribute to post-ischemic neuronal death
Caspase-8 is activated in models of Huntington's disease:
- Mutant huntingtin aggregation: Can trigger extrinsic apoptosis
- Death receptor upregulation: Fas and TRAIL-R are increased in HD models
- Bid cleavage: Contributes to mitochondrial dysfunction
- Therapeutic targeting: Caspase-8 inhibition is protective in some models
Caspase-8 is activated in ALS models and patient tissue:
- SOD1 mutations: Trigger caspase-8 activation in motor neurons
- TDP-43 pathology: Associated with caspase-8 activation
- Death receptor involvement: Fas signaling contributes to motor neuron death
- Astrocyte contributions: Mutant astrocytes trigger caspase-8 in co-cultured neurons
Caspase-8 has dual roles in autoimmune demyelination:
- Oligodendrocyte death: Caspase-8 contributes to myelin loss
- T cell activation: Required for activation-induced cell death (AICD)
- Remyelination failure: Caspase-8 inhibition may protect oligodendrocyte progenitors
Emerging evidence links COVID-19 to caspase-8 activation:
- Systemic inflammation: Cytokine storm includes TNF-α, activating caspase-8
- Blood-brain barrier: FasL can disrupt BBB
- Microglial activation: Caspase-8 in activated microglia
The extrinsic pathway is regulated at multiple levels:
Death receptor expression is dynamic in disease:
- Fas (CD95): Upregulated in AD, PD, HD, and stroke
- TNF-R1: Increased in neuroinflammation
- DR4/DR5 (TRAIL-R): Variable changes
¶ Ligand Expression
- FasL: Expressed on activated microglia, T cells, and some neurons
- TNF-α: Released by activated microglia and astrocytes
- TRAIL: Expressed in immune cells
- DcR1/DcR2: Decoy receptors that sequester ligands
- Soluble Fas: Alternative splicing generates soluble Fas
- Viral proteins: Some viruses express decoyDeath
c-FLIP (CFLAR) is a master regulator of caspase-8:
- c-FLIPL: Long isoform, catalytically inactive
- c-FLIPS: Short isoform, dominant-negative
- Regulation: c-FLIP is downregulated in some neurodegenerative conditions
- Therapeutic potential: c-FLIP overexpression protects neurons
Bid connects extrinsic and intrinsic pathways:
- Full-length Bid: Inactive until cleaved by caspase-8
- tBid: Truncated form, traffics to mitochondria
- Mitochondrial amplification: tBid triggers cytochrome c release
- Therapeutic targeting: Bid inhibitors block amplification
Caspase-8 cleaves substrates beyond executioner caspases:
| Substrate |
Cleavage Consequence |
| RIPK1 |
Prevents necroptosis (protective) |
| ROCK1 |
Alters cytoskeleton |
| MALT1 |
Modulates NF-κB |
| p75NTR |
Generates pro-apoptotic fragment |
| Presenilins |
May affect γ-secretase |
Caspase-8 is a critical suppressor of necroptosis:
- RIPK1 cleavage: Prevents necrosome formation
- RIPK3 binding: Blocks MLKL activation
- Switch function: Low caspase-8 → necroptosis
- Therapeutic implications: Caspase-8 inhibition can cause necroptosis
| Inhibitor |
Type |
Specificity |
Status |
| z-IETD-fmk |
Peptide mimetic |
Caspase-8 specific |
Research tool only |
| Ac-IETD-CHO |
Peptide aldehyde |
Caspase-8 specific |
Research tool only |
| CrmA (SerpB) |
Viral serpin |
Caspase-8 and granzyme B |
Research tool only |
| AEVD-fmk |
Peptide |
Broader caspase inhibitor |
Research tool only |
Clinical challenge: Broad caspase inhibition risks immunosuppression and tumor promotion. Selective targeting of neuronal caspase-8 activation is difficult.
- Decoy receptors: Soluble Fas/Fc proteins that sequester FasL before it reaches the receptor
- Death receptor blocking antibodies: Anti-Fas or anti-DR4/DR5 antibodies can block ligand binding
- Upstream modulation: Reducing TNF-α or FasL production (anti-inflammatory approaches)
- Bid inhibitors: Preventing Bid cleavage blocks the extrinsic-to-intrinsic amplification
- RIPK1 inhibitors (Necrostatin-1, GSK'872): Indirectly prevent caspase-8-mediated necroptosis suppression
Rather than globally inhibiting caspase-8, more targeted approaches include:
- Substrate-specific inhibitors: Blocking only harmful cleavages while preserving necessary functions
- Cell-penetrating peptides: Targeting the DISC or specific neuronal populations
- Gene therapy: siRNA or shRNA targeting CASP8 specifically in neurons
- Combination: Low-dose caspase-8 inhibition + anti-inflammatory + anti-excitotoxic approaches
| Partner |
Interaction Type |
Functional Consequence |
| FADD |
DED-DED binding |
DISC recruitment, activation |
| Fas (CD95) |
Indirect (via FADD) |
Death receptor signaling |
| TNF-R1 |
Indirect (via FADD) |
TNF-α signaling |
| DR4/DR5 |
Indirect (via FADD) |
TRAIL signaling |
| RIPK1 |
Substrate cleavage |
Necroptosis suppression |
| RIPK3 |
Protein interaction |
Blocks necrosome formation |
| Caspase-3 |
Substrate cleavage |
Executioner caspase activation |
| Caspase-7 |
Substrate cleavage |
Executioner caspase activation |
| Bid |
Substrate cleavage |
Links to mitochondrial pathway |
| c-FLIP (CFLAR) |
Heterodimerization |
Catalytic inhibition (dominant-negative) |
| IKK complex |
Substrate cleavage |
NF-κB activation (non-apoptotic) |
| PARP1 |
Substrate cleavage |
DNA repair inactivation |
| p75NTR |
Receptor |
proBDNF-mediated activation |